Literature DB >> 17562990

Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.

Prajna Lalitha1, Brett L Shapiro, Muthiah Srinivasan, Namperumalsamy Venkatesh Prajna, Nisha R Acharya, Annette W Fothergill, Jazmin Ruiz, Jaya D Chidambaram, Kathryn J Maxey, Kevin C Hong, Stephen D McLeod, Thomas M Lietman.   

Abstract

OBJECTIVE: To characterize the susceptibility of filamentous fungi isolated from keratitis to amphotericin B, natamycin, caspofungin acetate, itraconazole, voriconazole, and posaconazole.
METHODS: Ninety isolates from fungal keratitis cases at Aravind Eye Hospital in South India were tested using macrobroth dilution for susceptibility to amphotericin B, natamycin, caspofungin, itraconazole, voriconazole, and posaconazole. The minimum inhibitory concentration (MIC) median and 90th percentile were determined.
RESULTS: The 90 isolates included 41 Aspergillus species, 38 Fusarium species, and 11 others. The triazoles and caspofungin had the lowest MICs against Aspergillus species; voriconazole, amphotericin B, and posaconazole had the lowest MICs against Fusarium species, and none of the Fusarium species were inhibited by itraconazole or caspofungin. Amphotericin B had significantly lower MICs compared with natamycin, but after correcting for the typical prescription dose, natamycin was superior.
CONCLUSION: No single agent was universally most effective, but voriconazole and other triazoles demonstrated the broadest spectrum. Itraconazole and caspofungin were not effective against Fusarium species. CLINICAL RELEVANCE: Fungal ulcers are commonly treated empirically; drugs are typically selected without regard to susceptibility data. The nonocular infectious disease literature suggests modern fungal susceptibility methods are clinically relevant, but ocular studies are limited. Our results suggest antifungal therapy might be tailored to individual organisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562990     DOI: 10.1001/archopht.125.6.789

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  53 in total

1.  Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye.

Authors:  Deb K Mojumder; Francis A Concepcion; Shil K Patel; Andrew J Barkmeier; Petros E Carvounis; John H Wilson; Eric R Holz; Theodore G Wensel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.

Authors:  Prajna Lalitha; Brett L Shapiro; Allison R Loh; Annette W Fothergill; N Venkatesh Prajna; M Srinivasan; Catherine E Oldenburg; David A Quigley; Jaya D Chidambaram; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

3.  Recent outbreaks of atypical contact lens-related keratitis: what have we learned?

Authors:  Elmer Y Tu; Charlotte E Joslin
Journal:  Am J Ophthalmol       Date:  2010-11       Impact factor: 5.258

4.  Natamycin and Azithromycin Are Synergistic In Vitro against Ocular Pathogenic Aspergillus flavus Species Complex and Fusarium solani Species Complex Isolates.

Authors:  Haoyi Guo; Lutan Zhou; Yi He; Chuanwen Gao; Lei Han; Yan Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

5.  Fusarium keratitis and endophthalmitis associated with lens contact wear.

Authors:  Julia Proença-Pina; Isabelle Ssi Yan Kai; Tristan Bourcier; Monique Fabre; Hervé Offret; Marc Labetoulle
Journal:  Int Ophthalmol       Date:  2009-04-10       Impact factor: 2.031

6.  In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder.

Authors:  P Lalitha; R Vijaykumar; N V Prajna; A W Fothergill
Journal:  J Clin Microbiol       Date:  2008-08-13       Impact factor: 5.948

7.  Effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model.

Authors:  Yang Kyung Cho; Eun Young Shin; Hironori Uehara; Balamurali Ambati
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

8.  In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors:  Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Am J Ophthalmol       Date:  2013-10-22       Impact factor: 5.258

9.  Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.

Authors:  Zubair Ansari; Darlene Miller; Anat Galor
Journal:  Curr Fungal Infect Rep       Date:  2013-09-01

10.  Activity of antibiotics against Fusarium and Aspergillus.

Authors:  S Day; P Lalitha; S Haug; A W Fothergill; V Cevallos; R Vijayakumar; N V Prajna; N R Acharya; S D McLeod; T M Lietman
Journal:  Br J Ophthalmol       Date:  2008-10-24       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.